Correlation Between Atos SE and Acticor Biotech

Can any of the company-specific risk be diversified away by investing in both Atos SE and Acticor Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atos SE and Acticor Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Atos SE and Acticor Biotech SAS, you can compare the effects of market volatilities on Atos SE and Acticor Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atos SE with a short position of Acticor Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atos SE and Acticor Biotech.

Diversification Opportunities for Atos SE and Acticor Biotech

-0.38

Correlation Coefficient

Atos SE  Acticor Biotech

Very good diversification

The 3 months correlation between Atos and Acticor is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Atos SE and Acticor Biotech SAS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acticor Biotech SAS and Atos SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atos SE are associated (or correlated) with Acticor Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acticor Biotech SAS has no effect on the direction of Atos SE i.e., Atos SE and Acticor Biotech go up and down completely randomly.

Pair Corralation between Atos SE and Acticor Biotech

Assuming the 90 days trading horizon Atos SE is expected to generate 8.05 times more return on investment than Acticor Biotech. However, Atos SE is 8.05 times more volatile than Acticor Biotech SAS. It trades about 0.14 of its potential returns per unit of risk. Acticor Biotech SAS is currently generating about 0.03 per unit of risk. If you would invest  0.54  in Atos SE on September 3, 2024 and sell it today you would earn a total of  89.46  from holding Atos SE or generate 16566.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Atos SE  vs.  Acticor Biotech SAS

Atos SE

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Atos SE are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Atos SE sustained solid returns over the last few months and may actually be approaching a breakup point.

Acticor Biotech SAS

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Acticor Biotech SAS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Acticor Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Atos SE and Acticor Biotech

The main advantage of trading using opposite Atos SE and Acticor Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atos SE position performs unexpectedly, Acticor Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acticor Biotech will offset losses from the drop in Acticor Biotech's long position.

The idea behind Atos SE and Acticor Biotech SAS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.